v3.26.3
Loss Per Share
9 Months Ended
Sep. 30, 2026
Loss per common share:  
Loss Per Share

Note 7 – Loss Per Share

 

All share and per-share data, including basic and diluted loss per share and weighted average shares outstanding, have been retroactively adjusted to reflect the 1-for-30 reverse stock split effected on January 1, 2026, as if the reverse stock split had occurred at the beginning of the earliest period presented.

 

The following table reconciles the numerator and the denominator used to calculate basic and diluted loss per share for three and nine months ended September 30, 2026 and 2025, respectively:

 

   2026   2025   2026   2025 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2026   2025   2026   2025 
Numerator                    
Net loss, as reported  $(6,306,408)  $(5,886,823)  $(21,730,232)  $(21,150,211)
                     
Denominator                    
Weighted average shares, basic   6,272,635    1,263,031    4,293,424    1,145,695 
Dilutive effect of stock options, warrants and RSUs   -    -    -    - 
Shares used to compute diluted earnings per share   6,272,635    1,263,031    4,293,424    1,145,695 
                     
Loss per share, basic and diluted  $(1.01)  $(4.66)  $(5.06)  $(18.46)

 

 

The underlying common shares that were issued upon exercise of the pre-funded warrants issued in the May 2026 Private Placement were included in the calculation of basic weighted average number of common shares outstanding as of the date of issuance of the pre-funded warrants as the underlying common shares were issuable for little to no consideration and there were no vesting conditions or contingencies associated with the warrants.

 

As a result of incurring a net loss for the three and nine months ended September 30, 2026 and 2025, respectively, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. The Company had potentially dilutive securities as of September 30, 2026, consisting of: (i) 179,659 restricted stock units, (ii) 27,688 options, and (iii) 5,012,756 warrants. The Company had potentially dilutive securities as of September 30, 2025, consisting of: (i) 149,469 restricted stock units, (ii) 32,353 options, and (iii) 15,500 warrants.